Concerning in vivo tau imaging’s role in AD, the non-invasive assessment of the spatial and temporal pattern of tau deposition over time may provide an insight into the role tau plays in AD and may lead to establishing the relation between cognition, genotype, neurodegeneration, and other biomarkers in AD. Here, MAPT is linked to Alzheimer disease.